Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc announced that on March 4, 2026, it purchased 244,980 ordinary shares as part of its $250 million share repurchase program, with the volume-weighted average price paid per share being 1,254.07 pence. The company intends to cancel these repurchased shares, and following this transaction, holds 12,833,233 ordinary shares in treasury, with 220,858,734 ordinary shares currently in issue. Since February 26, 2026, Hikma has bought back a total of 1,027,719 shares for £13.2 million.

Disclaimer*

UK 100

Latest directors dealings